Literature DB >> 19028320

The pathophysiologic basis for epidemiologic trends in gastroesophageal reflux disease.

John E Pandolfino1, Monika A Kwiatek, Peter J Kahrilas.   

Abstract

Gastroesophageal reflux disease (GERD) is defined by either subjective complaints indicative of problematic gastroesophageal reflux or objective complications directly attributable to reflux. Studies focused on GERD-related symptoms suggest a worldwide increase in prevalence of approximately 4% per year. Epidemiologic data indicate that possible contributing factors include increasing longevity, rising obesity rates, greater consumption of medications affecting esophageal function, and potentially changing prevalence rates of Helicobacter pylori infection. This article explores the interplay between pathophysiology and epidemiology by focusing on these risk factors and their potential effect on GERD pathogenesis.

Entities:  

Mesh:

Year:  2008        PMID: 19028320     DOI: 10.1016/j.gtc.2008.09.009

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  9 in total

Review 1.  Lifestyle measures in the management of gastro-oesophageal reflux disease: clinical and pathophysiological considerations.

Authors:  J H-E Kang; J Y Kang
Journal:  Ther Adv Chronic Dis       Date:  2015-03       Impact factor: 5.091

Review 2.  Morbidity and mortality associated with obesity.

Authors:  Mahmoud Abdelaal; Carel W le Roux; Neil G Docherty
Journal:  Ann Transl Med       Date:  2017-04

3.  Beyond Belsey: complex laparoscopic hiatus and diaphragmatic hernia repair.

Authors:  D Zanotti; C Fiorani; A Botha
Journal:  Ann R Coll Surg Engl       Date:  2018-10-16       Impact factor: 1.891

Review 4.  Helicobacter pylori eradication and reflux disease onset: did gastric acid get "crazy"?

Authors:  Angelo Zullo; Cesare Hassan; Alessandro Repici; Vincenzo Bruzzese
Journal:  World J Gastroenterol       Date:  2013-02-14       Impact factor: 5.742

5.  Positive predictors for gastroesophageal reflux disease and the therapeutic response to proton-pump inhibitors.

Authors:  Valentin Becker; Stefan Grotz; Christoph Schlag; Simon Nennstiel; Analena Beitz; Bernhard Haller; Roland M Schmid; Alexander Meining; Monther Bajbouj
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

6.  Association between Increased Gastric Juice Acidity and Sliding Hiatal Hernia Development in Humans.

Authors:  Hiroshi Kishikawa; Kayoko Kimura; Asako Ito; Kyoko Arahata; Sakiko Takarabe; Shogo Kaida; Takanori Kanai; Soichiro Miura; Jiro Nishida
Journal:  PLoS One       Date:  2017-01-20       Impact factor: 3.240

7.  Effects of Osteopathic Visceral Treatment in Patients with Gastroesophageal Reflux: A Randomized Controlled Trial.

Authors:  Nuria Eguaras; Elena Sonsoles Rodríguez-López; Olga Lopez-Dicastillo; M Ángeles Franco-Sierra; François Ricard; Ángel Oliva-Pascual-Vaca
Journal:  J Clin Med       Date:  2019-10-19       Impact factor: 4.241

8.  Antibodies against gonadotropin-releasing hormone in patients with posterior laryngitis.

Authors:  Hillevi Pendleton; Ragnar Alm; Gunilla Nordin Fredrikson; Bodil Ohlsson
Journal:  Drug Target Insights       Date:  2013-01-28

9.  Adiponectin level changes among Egyptians with gastroesophageal reflux disease.

Authors:  Mohamed N Rafat; Hosni Abd-ElKareem Younus; Mohamed S El-Shorpagy; Mahmoud Haddad Hemida; Mohamed S El Shahawy; Ahmed Abd El Aziz El Sayed Atiia
Journal:  JGH Open       Date:  2018-01-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.